![Michael Heartlein](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael Heartlein
Keine laufenden Positionen mehr
Karriereverlauf von Michael Heartlein
Ehemalige bekannte Positionen von Michael Heartlein
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
TRANSLATE BIO, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2011 | 11.12.2019 |
Gründer | 01.01.2011 | 01.06.2020 | |
Corporate Officer/Principal | 11.12.2019 | 01.06.2020 | |
Shire Human Genetic Therapies, Inc.
![]() Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Corporate Officer/Principal | 01.01.2003 | 01.12.2016 |
Ausbildung von Michael Heartlein
Illinois State University | Undergraduate Degree |
Oak Ridge Graduate School of Biomedical Sciences | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 5 |
Operativ
Corporate Officer/Principal | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Translate Bio, Inc.
![]() Translate Bio, Inc. BiotechnologyHealth Technology Translate Bio, Inc. engages in the research and development of therapeutic drugs. It focuses on developing medicines to treat diseases caused by protein or gene dysfunction. Its lead product candidate, MRT5005 is designed for the treatment of cystic fibrosis. The company was founded by Arthur M. Krieg and Jeannie T. Lee in 2011 and is headquartered in Lexington, MA. | Health Technology |
Shire Human Genetic Therapies, Inc.
![]() Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Health Technology |
- Börse
- Insiders
- Michael Heartlein
- Erfahrung